Medtronic PLC 8-K Filing
Ticker: MDT · Form: 8-K · Filed: Nov 18, 2025 · CIK: 1613103
| Field | Detail |
|---|---|
| Company | Medtronic PLC (MDT) |
| Form Type | 8-K |
| Filed Date | Nov 18, 2025 |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Medtronic PLC (ticker: MDT) to the SEC on Nov 18, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.0001 (registered Ordinary shares, par value $0.0001 per share MDT New York Stock Exchange).
How long is this filing?
Medtronic PLC's 8-K filing is 2 pages with approximately 657 words. Estimated reading time is 3 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 657 words · 3 min read · ~2 pages · Grade level 9 · Accepted 2025-11-18 06:47:14
Key Financial Figures
- $0.0001 — registered Ordinary shares, par value $0.0001 per share MDT New York Stock Exchange
Filing Documents
- mdt-20251118.htm (8-K) — 61KB
- exhibit991-fy26q2earningsr.htm (EX-99.1) — 791KB
- image_0a.jpg (GRAPHIC) — 25KB
- 0001628280-25-052771.txt ( ) — 1197KB
- mdt-20251118.xsd (EX-101.SCH) — 6KB
- mdt-20251118_def.xml (EX-101.DEF) — 24KB
- mdt-20251118_lab.xml (EX-101.LAB) — 49KB
- mdt-20251118_pre.xml (EX-101.PRE) — 26KB
- mdt-20251118_htm.xml (XML) — 17KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition On November 18, 2025, Medtronic plc, a public limited company organized under the laws of Ireland, issued a press release announcing its second quarter fiscal year 2026 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report.
01. Exhibits
Item 9.01. Exhibits. (d) List of Exhibits Exhibit Number Description 99.1 Press release of Medtronic plc, dated November 18, 2025 104 Cover Page Interactive Data File (embedded with the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Medtronic plc By /s/ Thierry Piton Date: November 18, 2025 Thierry Piton Executive Vice President and Chief Financial Officer (Principal Financial Officer) EXHIBIT INDEX Exhibit Number Description 99.1 Press release of Medtronic plc, dated November 18, 2025 104 Cover Page Interactive Data File (embedded with the Inline XBRL document).